{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:43:30Z","timestamp":1792784610212,"version":"4.5.0"},"reference-count":38,"publisher":"American Chemical Society (ACS)","issue":"19","license":[{"start":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:00:00Z","timestamp":1790294400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:00:00Z","timestamp":1790294400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:00:00Z","timestamp":1790294400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-045"}],"funder":[{"DOI":"10.13039\/100013262","name":"State Key Laboratory of Respiratory Disease","doi-asserted-by":"publisher","award":["SKLRD-OP-202325"],"award-info":[{"award-number":["SKLRD-OP-202325"]}],"id":[{"id":"10.13039\/100013262","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004024","name":"Jinan University","doi-asserted-by":"publisher","award":["YXJC2024011"],"award-info":[{"award-number":["YXJC2024011"]}],"id":[{"id":"10.13039\/501100004024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2024A1515012557, 2024B1515040007"],"award-info":[{"award-number":["2024A1515012557, 2024B1515040007"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shenzhen Science and Technology Innovation Commission","award":["CJGJZD20220517142201004"],"award-info":[{"award-number":["CJGJZD20220517142201004"]}],"id":[{"id":"https:\/\/ror.org\/017n8df75","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Shenzhen Science and Technology Innovation Commission","award":["KJZD20240903100304007"],"award-info":[{"award-number":["KJZD20240903100304007"]}],"id":[{"id":"https:\/\/ror.org\/017n8df75","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Shenzhen Science and Technology Innovation Commission","award":["KQTD20210811090114013"],"award-info":[{"award-number":["KQTD20210811090114013"]}],"id":[{"id":"https:\/\/ror.org\/017n8df75","id-type":"ROR","asserted-by":"crossref"}]},{"name":"National Natural Science Foundation of China (NSFC)","award":["22477043"],"award-info":[{"award-number":["22477043"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Traditional drug discovery faces challenges from fragmented data, tacit knowledge dependence, and inefficient design-test cycles. We present an integrated AI workflow combining multimodal data curation, encoded medicinal chemistry rules, and physics-based simulations to establish a closed-loop from patent analysis to candidate validation. Application across six patents for four targets successfully deciphered SAR and identified representative molecules. A retrospective case study on RET kinase inhibitors demonstrated the workflow\u2019s efficiency: focusing on patent-derived SAR enabled rapid discovery of Cpd-31 (RET IC50 = 0.48 nM, 95.88% tumor inhibition at 10 mg\/kg) with only three initial compounds synthesized. This data-centric approach streamlines early drug discovery by providing objective molecular design foundations, significantly reducing synthetic efforts and hypothesis-driven exploration.<\/jats:p>","DOI":"10.1021\/acs.jmedchem.6c00340","type":"journal-article","created":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T17:03:50Z","timestamp":1790355830000},"page":"21762-21776","source":"Crossref","is-referenced-by-count":0,"title":["Integrating Multimodal AI with Encoded Medicinal Knowledge and Physics Simulations: A Unified Platform for Accelerated Drug Discovery from Patent Analysis to Potency Validation"],"prefix":"10.1021","volume":"69","author":[{"given":"Huimin","family":"Cheng","sequence":"first","affiliation":[{"name":"Shenzhen Jingtai Technology Co., Ltd. (XtalPi) , Floor 3, Sf Industrial Plant, No. 2 Hongliu Road, Fubao Community, Fubao Street, Futian District , ,","place":["Shenzhen, China, 518045"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuliang","family":"Wu","sequence":"additional","affiliation":[{"name":"Shenzhen Jingtai Technology Co., Ltd. (XtalPi) , Floor 3, Sf Industrial Plant, No. 2 Hongliu Road, Fubao Community, Fubao Street, Futian District , ,","place":["Shenzhen, China, 518045"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowen","family":"Niu","sequence":"additional","affiliation":[{"name":"Jinan University , , ,","place":["Guangzhou, China, 510632"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhang","family":"Wu","sequence":"additional","affiliation":[{"name":"Shenzhen Jingtai Technology Co., Ltd. (XtalPi) , Floor 3, Sf Industrial Plant, No. 2 Hongliu Road, Fubao Community, Fubao Street, Futian District , ,","place":["Shenzhen, China, 518045"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Zhou","sequence":"additional","affiliation":[{"name":"Shenzhen Jingtai Technology Co., Ltd. (XtalPi) , Floor 3, Sf Industrial Plant, No. 2 Hongliu Road, Fubao Community, Fubao Street, Futian District , ,","place":["Shenzhen, China, 518045"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjie","family":"Zou","sequence":"additional","affiliation":[{"name":"Shenzhen Jingtai Technology Co., Ltd. (XtalPi) , Floor 3, Sf Industrial Plant, No. 2 Hongliu Road, Fubao Community, Fubao Street, Futian District , ,","place":["Shenzhen, China, 518045"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huobin","family":"Wang","sequence":"additional","affiliation":[{"name":"Shenzhen Jingtai Technology Co., Ltd. (XtalPi) , Floor 3, Sf Industrial Plant, No. 2 Hongliu Road, Fubao Community, Fubao Street, Futian District , ,","place":["Shenzhen, China, 518045"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunwang","family":"Peng","sequence":"additional","affiliation":[{"name":"Shenzhen Jingtai Technology Co., Ltd. (XtalPi) , Floor 3, Sf Industrial Plant, No. 2 Hongliu Road, Fubao Community, Fubao Street, Futian District , ,","place":["Shenzhen, China, 518045"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqiang","family":"Liu","sequence":"additional","affiliation":[{"name":"Shenzhen Jingtai Technology Co., Ltd. (XtalPi) , Floor 3, Sf Industrial Plant, No. 2 Hongliu Road, Fubao Community, Fubao Street, Futian District , ,","place":["Shenzhen, China, 518045"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"He","sequence":"additional","affiliation":[{"name":"Jinan University , , ,","place":["Guangzhou, China, 510632"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijie","family":"Peng","sequence":"additional","affiliation":[{"name":"Jinan University , , ,","place":["Guangzhou, China, 510632"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongpan","family":"Chen","sequence":"additional","affiliation":[{"name":"Shenzhen Jingtai Technology Co., Ltd. (XtalPi) , Floor 3, Sf Industrial Plant, No. 2 Hongliu Road, Fubao Community, Fubao Street, Futian District , ,","place":["Shenzhen, China, 518045"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9331-9699","authenticated-orcid":true,"given":"Zhang","family":"Zhang","sequence":"additional","affiliation":[{"name":"Jinan University , , ,","place":["Guangzhou, China, 510632"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingjun","family":"Yang","sequence":"additional","affiliation":[{"name":"Shenzhen Jingtai Technology Co., Ltd. (XtalPi) , Floor 3, Sf Industrial Plant, No. 2 Hongliu Road, Fubao Community, Fubao Street, Futian District , ,","place":["Shenzhen, China, 518045"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Ma","sequence":"additional","affiliation":[{"name":"Shenzhen Jingtai Technology Co., Ltd. (XtalPi) , Floor 3, Sf Industrial Plant, No. 2 Hongliu Road, Fubao Community, Fubao Street, Futian District , ,","place":["Shenzhen, China, 518045"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2026,9,25]]},"reference":[{"issue":"7673","key":"2026100811082178100_cit1","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/549445a","article-title":"The drug-maker\u2019s guide to the galaxy","volume":"549","author":"Mullard","year":"2017","journal-title":"Nature"},{"issue":"3","key":"2026100811082178100_cit2","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/nrd3078","article-title":"How to improve R&D productivity: the pharmaceutical industry\u2019s grand challenge","volume":"9","author":"Paul","year":"2010","journal-title":"Nat. Rev. Drug Discovery"},{"issue":"7958","key":"2026100811082178100_cit3","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/s41586-023-05905-z","article-title":"Computational approaches streamlining drug discovery","volume":"616","author":"Sadybekov","year":"2023","journal-title":"Nature"},{"issue":"6","key":"2026100811082178100_cit4","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/s41573-019-0024-5","article-title":"Applications of machine learning in drug discovery and development","volume":"18","author":"Vamathevan","year":"2019","journal-title":"Nat. Rev. Drug Discovery"},{"issue":"1","key":"2026100811082178100_cit5","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41591-024-03434-4","article-title":"Artificial intelligence in drug development","volume":"31","author":"Zhang","year":"2025","journal-title":"Nat. Med."},{"issue":"6","key":"2026100811082178100_cit6","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1039\/d4dd00011k","article-title":"Mining patents with large language models elucidates the chemical function landscape","volume":"3","author":"Kosonocky","year":"2024","journal-title":"Digital Discovery"},{"issue":"6","key":"2026100811082178100_cit7","doi-asserted-by":"publisher","first-page":"2720","DOI":"10.1021\/acs.jcim.0c01329","article-title":"A Cloud Computing Platform for Scalable Relative and Absolute Binding Free Energy Predictions: New Opportunities and Challenges for Drug Discovery","volume":"61","author":"Lin","year":"2021","journal-title":"J. Chem. Inf. Model."},{"issue":"1\u22122","key":"2026100811082178100_cit8","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/s1359-6446(05)03682-2","article-title":"Mining chemical structural information from the drug literature","volume":"11","author":"Banville","year":"2006","journal-title":"Drug Discovery Today"},{"issue":"6","key":"2026100811082178100_cit9","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1016\/j.drudis.2018.01.039","article-title":"The rise of deep learning in drug discovery","volume":"23","author":"Chen","year":"2018","journal-title":"Drug Discovery Today"},{"issue":"2","key":"2026100811082178100_cit10","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1021\/acs.accounts.0c00699","article-title":"Applications of deep learning in molecule generation and molecular property prediction","volume":"54","author":"Walters","year":"2020","journal-title":"Acc. Chem. Res."},{"key":"2026100811082178100_cit11","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.ymeth.2023.12.009","article-title":"Application scenario-oriented molecule generation platform developed for drug discovery","volume":"222","author":"Zheng","year":"2024","journal-title":"Methods"},{"issue":"8","key":"2026100811082178100_cit12","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1021\/acs.jcim.2c00072","article-title":"AutoDesigner, a De Novo Design Algorithm for Rapidly Exploring Large Chemical Space for Lead Optimization: Application to the Design and Synthesis of d-Amino Acid Oxidase Inhibitors","volume":"62","author":"Bos","year":"2022","journal-title":"J. Chem. Inf. Model."},{"issue":"3","key":"2026100811082178100_cit13","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1021\/acs.jcim.2c01191","article-title":"Chemistry42: An AI-Driven Platform for Molecular Design and Optimization","volume":"63","author":"Ivanenkov","year":"2023","journal-title":"J. Chem. Inf. Model."},{"issue":"2","key":"2026100811082178100_cit14","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1021\/acs.jctc.3c00920","article-title":"Development and Comprehensive Benchmark of a High-Quality AMBER-Consistent Small Molecule Force Field with Broad Chemical Space Coverage for Molecular Modeling and Free Energy Calculation","volume":"20","author":"Xue","year":"2024","journal-title":"J. Chem. Theory Comput."},{"key":"2026100811082178100_cit15","doi-asserted-by":"publisher","first-page":"932353","DOI":"10.3389\/fonc.2022.932353","article-title":"RET signaling pathway and RET inhibitors in human cancer","volume":"12","author":"Regua","year":"2022","journal-title":"Front. Oncol."},{"issue":"6","key":"2026100811082178100_cit16","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.21037\/tlcr-20-346","article-title":"Decade in review: a new era for RET-rearranged lung cancers","volume":"9","author":"Choudhury","year":"2020","journal-title":"Transl. Lung Cancer Res."},{"issue":"3","key":"2026100811082178100_cit17","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.annonc.2020.11.021","article-title":"ESMO recommendations on the standard methods to detect RET fusions and mutations in daily practice and clinical research","volume":"32","author":"Belli","year":"2021","journal-title":"Ann. Oncol."},{"issue":"3","key":"2026100811082178100_cit18","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/nrclinonc.2017.175","article-title":"Targeting RET-driven cancers: lessons from evolving preclinical and clinical landscapes","volume":"15","author":"Drilon","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"8","key":"2026100811082178100_cit19","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1016\/j.cellsig.2014.03.032","article-title":"Mechanisms of RET signaling in cancer: current and future implications for targeted therapy","volume":"26","author":"Plaza-Menacho","year":"2014","journal-title":"Cell. Signal."},{"key":"2026100811082178100_cit20","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.jfma.2025.06.033","article-title":"Four decades of the RET gene: From discovery to tumor-agnostic therapy","volume":"124","author":"Takahashi","year":"2025","journal-title":"J. Formos. Med. Assoc."},{"issue":"Suppl 1","key":"2026100811082178100_cit21","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.35779","article-title":"Treatment of non-small cell lung cancer with RET rearrangements","volume":"131","author":"Hoe","year":"2025","journal-title":"Cancer"},{"issue":"2","key":"2026100811082178100_cit22","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s11684-023-0985-y","article-title":"Progress and challenges in RET-targeted cancer therapy","volume":"17","author":"Hu","year":"2023","journal-title":"Front. Med."},{"key":"2026100811082178100_cit23","doi-asserted-by":"publisher","first-page":"103882","DOI":"10.1016\/j.critrevonc.2022.103882","article-title":"Targeting RET alterations in cancer: Recent progress and future directions","volume":"181","author":"Shabbir","year":"2023","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"4","key":"2026100811082178100_cit24","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1158\/2159-8290.cd-19-1116","article-title":"Advances in Targeting RET-Dependent Cancers","volume":"10","author":"Subbiah","year":"2020","journal-title":"Cancer Discov."},{"issue":"1","key":"2026100811082178100_cit25","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3390\/cancers16010031","article-title":"Selective RET Inhibitors (SRIs) in Cancer: A Journey from Multi-Kinase Inhibitors to the Next Generation of SRIs","volume":"16","author":"Clark","year":"2023","journal-title":"Cancers"},{"issue":"8","key":"2026100811082178100_cit26","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1080\/07357907.2023.2255655","article-title":"Efficacy and Safety of RET-Specific Kinase Inhibitors in RET-Altered Cancers: A Systematic Review","volume":"41","author":"Ali","year":"2023","journal-title":"Cancer Invest."},{"issue":"10","key":"2026100811082178100_cit27","doi-asserted-by":"publisher","first-page":"406","DOI":"10.46883\/ONC.2020.3410.0406","article-title":"FDA Approves Pralsetinib for Treatment of Adults With Metastatic RET Fusion-Positive NSCLC","volume":"34","author":"Wright","year":"2020","journal-title":"Oncology"},{"issue":"20","key":"2026100811082178100_cit28","doi-asserted-by":"publisher","first-page":"5452","DOI":"10.1158\/1078-0432.ccr-21-0967","article-title":"FDA Approval Summary: Pralsetinib for the Treatment of Lung and Thyroid Cancers With RET Gene Mutations or Fusions","volume":"27","author":"Kim","year":"2021","journal-title":"Clin. Cancer Res."},{"issue":"11","key":"2026100811082178100_cit29","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1007\/s40265-020-01343-7","article-title":"Selpercatinib: First Approval","volume":"80","author":"Markham","year":"2020","journal-title":"Drugs"},{"issue":"8","key":"2026100811082178100_cit30","doi-asserted-by":"publisher","first-page":"2130","DOI":"10.1158\/1078-0432.ccr-20-3558","article-title":"FDA Approval Summary: Selpercatinib for the Treatment of Lung and Thyroid Cancers with RET Gene Mutations or Fusions","volume":"27","author":"Bradford","year":"2021","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"2026100811082178100_cit31","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1021\/ci800067r","article-title":"Optical Structure Recognition Software To Recover Chemical Information: OSRA, An Open Source Solution","volume":"49","author":"Filippov","year":"2009","journal-title":"J. Chem. Inf. Model."},{"issue":"7","key":"2026100811082178100_cit32","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1021\/acs.jcim.2c01480","article-title":"MolScribe: Robust Molecular Structure Recognition with Image-to-Graph Generation","volume":"63","author":"Qian","year":"2023","journal-title":"J. Chem. Inf. Model."},{"issue":"2","key":"2026100811082178100_cit33","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.annonc.2020.10.599","article-title":"Structural basis of acquired resistance to selpercatinib and pralsetinib mediated by non-gatekeeper RET mutations","volume":"32","author":"Subbiah","year":"2021","journal-title":"Ann. Oncol."},{"key":"2026100811082178100_cit34","unstructured":"Cheng, H.; Wen, X.; Liu, Z.; Fang, L.; Chen, Y.; Wei, Y.; Zhang, G.; Li, C.; Ma, S.; Qi, Z.; Pyrazolo[1,5-a]pyridine derivative, preparation method therefor, and composition and use thereof. WO 2021213476 A1, 2021."},{"issue":"16_suppl","key":"2026100811082178100_cit35","doi-asserted-by":"publisher","first-page":"6098","DOI":"10.1200\/JCO.2025.43.16_suppl.6098","article-title":"Results from a phase I study of KL590586 in patients with advanced RET-mutant medullary thyroid cancer","volume":"43","author":"Zheng","year":"2025","journal-title":"J. Clin. Oncol."},{"key":"2026100811082178100_cit36","unstructured":"Chen, Z.; Duan, S.; Li, G.; Han, R.; Sun, Q.; Jing, L.; Han, X.; Tian, Q.; Song, H.; Ji, X., XueT., WangJ.\n          Heterocyclic compound, pharmaceutical composition comprising same, preparation method therefor, and use thereof. WO 2020168939 A1, 2019."},{"key":"2026100811082178100_cit37","unstructured":"Yang, R.; Jin, H.; Dou, F.\n          Method for identifying specific position on specific route and electronic device. WO 2020168929 A12020."},{"key":"2026100811082178100_cit38","doi-asserted-by":"publisher","first-page":"114862","DOI":"10.1016\/j.ejmech.2022.114862","article-title":"1-Methyl-3-((4-(quinolin-4-yloxy)phenyl)amino)-1H-pyrazole-4-carboxamide derivatives as new rearranged during Transfection (RET) kinase inhibitors capable of suppressing resistant mutants in solvent-front regions","volume":"244","author":"Zhang","year":"2022","journal-title":"Eur. J. Med. Chem."}],"container-title":["Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.jmedchem.6c00340","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article-pdf\/69\/19\/21762\/68661731\/jm6c00340.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article-pdf\/69\/19\/21762\/68661731\/jm6c00340.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T15:30:58Z","timestamp":1791473458000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article\/69\/19\/21762\/5439046\/Integrating-Multimodal-AI-with-Encoded-Medicinal"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,25]]},"references-count":38,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2026,9,25]]},"published-print":{"date-parts":[[2026,10,8]]}},"URL":"https:\/\/doi.org\/10.1021\/acs.jmedchem.6c00340","relation":{},"ISSN":["0022-2623","1520-4804"],"issn-type":[{"value":"0022-2623","type":"print"},{"value":"1520-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,25]]}}}